Lemaitre Vascular (LMAT) Depreciation & Amortization (CF) (2010 - 2026)

Lemaitre Vascular (LMAT) has 17 years of Depreciation & Amortization (CF) data on file, last reported at $2.6 million in Q1 2026.

• Depreciation & Amortization (CF) for Q1 2026 came in at $2.6 million, up 2.78% year-over-year; the trailing twelve-month figure through Mar 2026 was $10.5 million (up 7.27% YoY), and the FY2025 annual result was $10.4 million, up 8.43% from the prior year.
• Depreciation & Amortization (CF) rose to $2.6 million in Q1 2026 per LMAT's latest filing, from $2.6 million in the prior quarter.
• Over five years, Depreciation & Amortization (CF) peaked at $2.6 million in Q2 2025 and troughed at $2.3 million in Q4 2022.
• A 5-year average of $2.4 million and a median of $2.4 million in 2024 frame the typical range for Depreciation & Amortization (CF).
• The sharpest annual moves came in 2022 and 2025: Depreciation & Amortization (CF) fell 20.67% in 2022, then gained 11.07% in 2025.
• A 5-year view of Depreciation & Amortization (CF) shows it stood at $2.3 million in 2022, then climbed by 6.77% to $2.4 million in 2023, then dropped by 1.11% to $2.4 million in 2024, then grew by 7.82% to $2.6 million in 2025, then climbed by 0.69% to $2.6 million in 2026.
• Business Quant data shows LMAT's Depreciation & Amortization (CF) at $2.6 million in Q1 2026, $2.6 million in Q4 2025, and $2.6 million in Q3 2025.